GleamWall
中文EN

BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.

Laboratory Analytical Instruments · OTC · SEC CIK 1310488 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY75.0%
TTM EPS YoY80.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-44.3%
ROA-28.9%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets12.4%
Debt / equity0.00x
Current ratio7.23x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.39x
Accruals ratio-17.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
SG&A expense$307,930$118,580$11,983$12,048$10,165$17,031$27,707$17,410
Operating income————-$115,915-$122,781-$133,457—
Pretax income-$341,680-$262,330-$117,733-$117,798-$115,915-$122,781-$133,457—
Net income-$341,680$238,682-$102,411-$118,605-$115,915-$122,781-$935,457-$123,160
EPS (basic)-0.010.010.00—0.000.00-0.03—
EPS (diluted)-0.010.010.00—0.000.00-0.03—
Weighted avg. shares (diluted)35.04M33.54M33.52M—33.52M33.52M32.25M—
Balance sheet
Cash & equivalents$31,696$307$6,347$786$784$905$13,799$862
Current assets$2.00M$2.15M$6,347$786$784$905$13,799$862
Total assets$2.24M$2.39M$6,347$786$784$905$13,799$862
Current liabilities$277,033$84,767$727,301$619,329$500,722$384,928$275,041$2.30M
Total liabilities$277,033$84,767$727,301$619,329$500,722$384,928$275,041$2.30M
Shareholders' equity$1.96M$2.30M-$720,954-$618,543-$499,938-$384,023-$261,242-$2.30M
Shares outstanding38.07M33.55M33.52M33.52M33.52M33.52M33.52M29.27M
Cash flow statement
Operating cash flow-$94,790-$26,980$7,088-$10,921-$11,121-$27,893-$15,215-$14,835
Financing cash flow$126,179$20,940-$1,527$10,923$11,000$14,999$28,152$14,062

Free plan shows the latest 8 periods; Pro shows all 37 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.